Release test results
99.606%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 50.25 mg
Related impurities (total)0.394%
Endotoxin<1.0 EU/mg
HPLC retention time6.44 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundGHK-CU
Presentation50 MG
Lot numberRGX-26-RGNX-1055
COA numberNS-2026-05056
Test date11 Jul 2026
Release date14 Jul 2026
Independent labNordicstar Labs
StatusCurrent
GHK-CU — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-RGNX-1055 this lot | 50 MG | Jul 11, 2026 | 99.606% | Current |
| RGX-26-RGNX-1056 | 100 MG | Jul 11, 2026 | 99.568% | Current |
| RGX-26-RGNX-744 | 100 MG | Mar 30, 2026 | 99.669% | Superseded |
| RGX-26-RGNX-745 | 50 MG | Mar 28, 2026 | 99.745% | Superseded |
| RGX-26-RGNX-644 | 100 MG | Jan 8, 2026 | 99.769% | Superseded |
| RGX-25-RGNX-645 | 50 MG | Dec 29, 2025 | 99.707% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →